SkinHealth Systems Inc. (Nasdaq: SKIN) is a special purpose acquisition company focused on the healthcare and medical-aesthetics sector. The company filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on August 12, 2026, accession number 0001683168-26-006273, signaling that a shareholder vote is pending — typically tied to a proposed business combination or trust extension. The sponsor name was not independently confirmed at publication time. The filing reflects the company's active status within the SPAC lifecycle as it seeks shareholder approval for its next corporate action. For the full filing history, deal terms, shareholder vote details, and real-time status updates on SKIN, sign up for complete data access at SpacDesk.